Increase in Technological Advancements Coupled with Burden of Cardiovascular Diseases to Drive Pacemaker Market over the Forecast Period: Ken Research

0


The pacemaker is an artificial or non-natural device implanted in the chest that produces low-energy electrical pulses to control the abnormal heart rhythm. They are used in the medical conditions for instance arrhythmia, heart block, atrial fibrillation, and long QT syndrome. The devices are the preferred alternative of treatment in cardiovascular diseases due to non-invasive nature of these devices. The use of pacemaker devices comes with the numerous complications like operational failure, due to use of battery depletion, random component failure or mishandling, connected with the temporary external pacemakers.

According to study, “Pacemaker Market – Global Forecasts upto 2024” some of the major companies that are currently working in the pacemaker market are Abbott Laboratories, Inc. (St. Jude Medical, Inc.), Medtronic, Boston Scientific Corporation, Oscor Inc., SORIN Group, BIOTRONIK SE & Co. KG, MicroPort Scientific Corporation, Livanova, Lepu Medical Technology Co. Ltd., Osypka Medical GmbH, Qinming Medical, Vitatron Holding B.V., Medico, S.p.A, Shree Pacetronix Ltd. Several market vendors in the emerging economies such as Middle East & Asia-Pacific have resulted into products compatible with concert levels so that of high-end implantable cardiac pacemakers at reasonable costs can be manufactured.

Based on type, the pacemakers market is segmented into conventional pacemakers and MRI compatible pacemakers. Based on device type, market is separated into external pacemakers and implantable pacemakers. The external cardiac pacemaker is used for momentary pacing & requires a fully furbished medical facility. The implantable pacemaker device is located under the skin on left side of the chest, and is connected with leads guided by a blood vessel to the heart. Based on technology, market is classified into single chamber pacemakers, dual chamber pacemakers and biventricular or CRT pacemakers. Single-chamber pacemaker fixes pulse generator to one of the chambers of heart. Dual-chamber pacemaker includes two leads, which are placed in ventricle and right atrium. Additionally, biventricular pacemaker is used in patient that illustrates lack of synchronization between contractions of the right & a left ventricle, which is a most ordinary condition, known as ventricular desynchrony. Based on usage, market is classified into heart block, arrhythmia, atrial fibrillation, tachycardia, bradycardia and long QT syndrome. The arrhythmia heart is not able to pump sufficient blood to the other parts of the body, which causes fainting & fatigue. Arrhythmia is of two types, bradycardia and tachycardia. When the heart beat is too slow it is termed as bradycardia and when it is too slow it is known as tachycardia. Moreover, based on end-user type, market is described as ambulatory surgical centers (ASCs) and hospitals & cardiac centers.

The global pacemaker market is driven by the increase in technological advancements. Some other driven aspects are increasing burden of cardiovascular diseases (CVD), combined efforts of government & domestic players, various supportive government initiatives, food reimbursement facilities, increasing research & development (R&D) investments and increasing aging population. Apart from benefits, some of the restraints include unfavorable reimbursement scenario, high cost of pacemakers, stringent regulatory approval process, side effect of pacemakers and lack of skilled healthcare professionals. Furthermore, market is also impacted by the key challenges that include frequent product recalls and shortage of cardiac surgeons. Moreover, the key opportunities associated include implantable micro pacemakers designed for fetal use and emerging markets.

In the upcoming years, future of global pacemaker market is expected to be bright due to increase in the availability of skilled physicians & healthcare practitioners.

For more information, click on the link below:

Pacemaker Market

Contact Us:                                     

Ken Research

Ankur Gupta, Head Marketing & Communications

sales@kenresearch.com

+91 9015378249

Share.